why choose us

First received: April 11, 2023

Clinical Trial: Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Latent Tuberculosis Infection

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-blind, Controlled Phase ? Trial of Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) for the Diagnosis of Mycobacterium Tuberculosis Infection in 65-year-old

Brief Summary: A multicenter, randomized, blind, controlled trial design was used to select 240 tuberculosis (TB) patients, 120 non-tuberculous community population with other lung diseases, and 420 healthy community population without other lung diseases who met the inclusion criteria of this study.Blood supply specific gamma-interferon (T-SPOT) detection was performed first.Then, EC and Purified Protein derivation of tuberculin (TB-PPD) skin tests were performed on both arms, and the recorded results were observed.The first 24…

Read more